Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

ATP (Apple Tree Partners)

Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • Tel Aviv
  • Israel
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Pharma
  • Health Tech
  • Medical Devices
  • Digital Health
  • Life Sciences
About
Apple Tree Partners (ATP) is a leading life sciences venture capital firm that creates transformative biotechnology companies, investing from seed stage to IPO and beyond to improve human lives.
Min check size
$10M
Max check size
$25M
Fund size
NPS

Investment Thesis

ATP focuses on creating and investing in transformative biotechnology companies. They provide flexible capital, strategic insight, and operational resources to build sustainable, researchdriven enterprises. ATP invests in companies from preIP ideas to asset spinouts and supports them from Seed stage through IPO and beyond.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Focused on early-stage investments within the technology and healthcare sectors. Known for a significant presence in North American markets, having backed over 40 companies. Specializes in identifying disruptive innovations with a hands-on, operational approach. Recognized for achieving numerous successful exits, reflecting a strong track record in value creation.

ATP (Apple Tree Partners) Contacts Information

Primary contact

Secondary contact

Team

Stephen Dance

Seth Harrison

Sam Hall

Sally Jacob

Preston Brice

Marie Afif

Lisa Cagney

Lauren Farrell

Huw Nash

Garry Neil

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp